Discussion of EMA Draft Guideline on Quality and Equivalence of Topical Products Based on Comparison of Approved Mometasone Furoate Drugs.
Adina EichnerYahya MrestaniMartin HukaufJohannes WohlrabPublished in: Dermatology and therapy (2024)
This bioequivalence study shows insufficient parameters, which should be discussed together with the EMA draft guideline.
Keyphrases